0001209191-17-050698.txt : 20170830
0001209191-17-050698.hdr.sgml : 20170830
20170830160936
ACCESSION NUMBER: 0001209191-17-050698
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170829
FILED AS OF DATE: 20170830
DATE AS OF CHANGE: 20170830
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Primiano Christopher Brett
CENTRAL INDEX KEY: 0001603510
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36167
FILM NUMBER: 171060800
MAIL ADDRESS:
STREET 1: C/O KARYOPHARM THERAPEUTICS INC.
STREET 2: 85 WELLS AVENUE, SECOND FLOOR
CITY: NEWTON
STATE: MA
ZIP: 02459
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Karyopharm Therapeutics Inc.
CENTRAL INDEX KEY: 0001503802
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263931704
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 85 WELLS AVENUE
STREET 2: SECOND FLOOR
CITY: NEWTON
STATE: MA
ZIP: 02459
BUSINESS PHONE: 617-658-0600
MAIL ADDRESS:
STREET 1: 85 WELLS AVENUE
STREET 2: SECOND FLOOR
CITY: NEWTON
STATE: MA
ZIP: 02459
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-08-29
0
0001503802
Karyopharm Therapeutics Inc.
KPTI
0001603510
Primiano Christopher Brett
C/O KARYOPHARM THERAPEUTICS INC.
85 WELLS AVENUE
NEWTON
MA
02459
0
1
0
0
SVP, OPS, BUS DEV, GC & SEC
Common Stock
2017-08-29
4
S
0
2195
10.00
D
15686
D
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Includes 2,062 shares acquired under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan.
/s/ Christopher B. Primiano
2017-08-30